Literature DB >> 7693981

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.

D A Ackerman1, J M Barry, R A Wicklund, N Olson, B A Lowe.   

Abstract

We analyzed data from 107 consecutive patients with clinical stage B prostate cancer in an attempt to identify those at high risk for having involved margins or nodal metastasis. Each patient underwent transrectal ultrasound-guided sextant biopsies of the prostate. Patient age, surgical approach to prostatectomy, pre-biopsy prostate specific antigen (PSA) level, and number, location and maximum Gleason score of positive biopsies were statistically evaluated for all patients groups. Prostate volume and PSA density (PSAD) were calculated for all patients undergoing prostatectomy. Of the 101 patients who underwent radical prostatectomy 64 had negative margins, 37 had at least 1 positive margin and 11 of the 37 had more than 1 positive margin. Involved margins were most common at the apex (62%) and mid portion (59%) of the gland. Prostatectomy was not performed on 6 patients with nodal metastases evident on frozen section examination. Therefore, 43 patients are considered to be at high risk for having residual disease after surgery. The mean PSAD, PSA level and number of positive biopsies were significant (p < 0.05) predictors of tumor extension to the surgical margin. The mean number of positive biopsies, biopsy Gleason score and PSA level were significantly greater (p < 0.05) in patients with nodal metastases. Only 15% of the patients with a single positive biopsy had positive margins versus 47% of those with multiple positive biopsies (p < 0.05). Of the patients with tumor positive nodes on frozen section 67% had 5 or more positive biopsies, whereas only 9% of all others had that many positive biopsies (p < 0.05). The number of positive biopsy sites, PSAD and PSA level were significantly associated with tumor at the surgical margin or metastatic to the pelvic nodes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693981     DOI: 10.1016/s0022-5347(17)35912-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).

Authors:  Theodorus H van der Kwast; Laurence Collette; Hein Van Poppel; Paul Van Cangh; Kris Vekemans; Luigi DaPozzo; Jean-François Bosset; Karl H Kurth; Fritz H Schröder; Michel Bolla
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

Review 2.  Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.

Authors:  D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

3.  Correlation between Gleason score of needle biopsy and radical prostatectomy tissue.

Authors:  M Cecchi; R Minervini; C A Sepich; C Ippolito; G L Pagni; D Summonti; A Di Benedetto; L Fiorentini
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

4.  Safe-R: a novel score, accounting for oncological safe nerve-sparing at radical prostatectomy for localized prostate cancer.

Authors:  Andreas Becker; Carolina Coelius; Meike Adam; Pierre Tennstedt; Luis Kluth; Thomas Steuber; Hans Heinzer; Markus Graefen; Thorsten Schlomm; Uwe Michl
Journal:  World J Urol       Date:  2014-03-26       Impact factor: 4.226

Review 5.  Critical review of prostate cancer predictive tools.

Authors:  Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

6.  Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer?

Authors:  W F Thon; F Gadban; M C Truss; M Kuczyk; U Hartmann; U Jonas
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

7.  Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men.

Authors:  Cheryn Song; Taejin Kang; Jae Y Ro; Moo-Song Lee; Choung-Soo Kim; Hanjong Ahn
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

8.  The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer.

Authors:  Erim Erdem; Necmettin Atsü; Cem Akbal; Cenk Y Bilen; Ali Ergen; Haluk Ozen
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  Positive surgical margins during robotic radical prostatectomy: a contemporary analysis of risk factors.

Authors:  Michael Liss; Kathryn Osann; David Ornstein
Journal:  BJU Int       Date:  2008-04-24       Impact factor: 5.588

10.  Iatrogenic and non-iatrogenic positive margins: incidence, site, factors involved, and time to PSA progression following radical prostatectomy.

Authors:  Athanase Billis; Isabela C Watanabe; Matheus V Costa; Gilliat H Telles; Luis A Magna
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.